<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Abundnz</title>
	<atom:link href="http://www.abundnz.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.abundnz.com</link>
	<description>Analytical support for biomedical and innovative medicines research</description>
	<lastBuildDate>Sun, 14 Apr 2013 19:37:09 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Abundnz presents latest results at ASMS 2013</title>
		<link>http://www.abundnz.com/news/abundnz-presents-latest-results-at-asms-2013/</link>
		<comments>http://www.abundnz.com/news/abundnz-presents-latest-results-at-asms-2013/#comments</comments>
		<pubDate>Sun, 14 Apr 2013 19:37:09 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=492</guid>
		<description><![CDATA[Abundnz will present their latest results about their innovative pAMS technology at ASMS 2013 in Minneapolis (USA).]]></description>
			<content:encoded><![CDATA[<p>Abundnz will present their latest results about their innovative pAMS technology at ASMS 2013 in Minneapolis (USA).</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/abundnz-presents-latest-results-at-asms-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abundnz highlighted in Dutch magazine about drug research</title>
		<link>http://www.abundnz.com/news/abundnz-highlighted-in-dutch-magazine-about-drug-research/</link>
		<comments>http://www.abundnz.com/news/abundnz-highlighted-in-dutch-magazine-about-drug-research/#comments</comments>
		<pubDate>Thu, 21 Feb 2013 19:55:09 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=488</guid>
		<description><![CDATA[In the first edition of 2013 of the Dutch magazine Medicines, special attention is paid to Abundnz and its innovative pAMS technology. Medicines is an independent journal writing about drug research in the Netherlands. &#160;]]></description>
			<content:encoded><![CDATA[<p>In the <a title="Medicines" href="http://www.c2w.nl/vakblad-medicines/inhoud-medicines-1-2013.309532.lynkx" target="_blank">first edition of 2013</a> of the Dutch magazine Medicines, special attention is paid to Abundnz and its innovative pAMS technology. Medicines is an independent journal writing about drug research in the Netherlands.</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/abundnz-highlighted-in-dutch-magazine-about-drug-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biopharma UK</title>
		<link>http://www.abundnz.com/news/biopharma-uk/</link>
		<comments>http://www.abundnz.com/news/biopharma-uk/#comments</comments>
		<pubDate>Mon, 04 Feb 2013 20:18:52 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=477</guid>
		<description><![CDATA[Abundnz and UK based company ImmunoSYS have agreed to work in partnership to further develop and commercialise our pAMS technology. The tool originally developed by Abundnz is expected to offer drug discovery companies an advanced and better analysis option.]]></description>
			<content:encoded><![CDATA[<p>Abundnz and UK based company ImmunoSYS have agreed to work in partnership to further develop and commercialise our pAMS technology. The tool originally developed by Abundnz is expected to offer drug discovery companies an advanced and better analysis option.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/biopharma-uk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Happy New Year</title>
		<link>http://www.abundnz.com/news/happy-new-year/</link>
		<comments>http://www.abundnz.com/news/happy-new-year/#comments</comments>
		<pubDate>Tue, 08 Jan 2013 20:39:40 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=474</guid>
		<description><![CDATA[Abundnz wishes all their relations a very Happy New Year! We look forward to continue our collaborations with you.]]></description>
			<content:encoded><![CDATA[<p>Abundnz wishes all their relations a very Happy New Year! We look forward to continue our collaborations with you.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/happy-new-year/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abundnz finalist in Accenture Innovation Awards 2012</title>
		<link>http://www.abundnz.com/news/abundnz-finalist-in-accenture-innovation-awards-2012/</link>
		<comments>http://www.abundnz.com/news/abundnz-finalist-in-accenture-innovation-awards-2012/#comments</comments>
		<pubDate>Mon, 17 Dec 2012 19:41:34 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=463</guid>
		<description><![CDATA[Abundnz participated in the competition for the Accenture Innovation Awards 2012. Our company ended as finalist, and the pAMS technology platform was thus elected to belong to the top of Dutch innovative concepts. &#160;]]></description>
			<content:encoded><![CDATA[<p><img class="alignleft size-full wp-image-464" style="border: 0px none; margin: 0px;" title="innovation-awards-banner-finalist-1.0.png" src="http://www.abundnz.com/wp-content/uploads/innovation-awards-banner-finalist-1.0.png.png" alt="" width="161" height="161" />Abundnz participated in the competition for the Accenture Innovation Awards 2012. Our company ended as finalist, and the pAMS technology platform was thus elected to belong to the top of Dutch innovative concepts.</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/abundnz-finalist-in-accenture-innovation-awards-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Publication accepted</title>
		<link>http://www.abundnz.com/news/publication-accepted/</link>
		<comments>http://www.abundnz.com/news/publication-accepted/#comments</comments>
		<pubDate>Fri, 07 Dec 2012 20:16:44 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=460</guid>
		<description><![CDATA[A publication on the use of pAMS in biotech drug development has appeared in Bioanalysis 5(1) 53-63 (2013).]]></description>
			<content:encoded><![CDATA[<p>A publication on the use of pAMS in biotech drug development has appeared in <a title="Bioanalysis" href="http://www.ncbi.nlm.nih.gov/pubmed/23256472" target="_blank">Bioanalysis 5(1) 53-63 (2013)</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/publication-accepted/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abundnz on television</title>
		<link>http://www.abundnz.com/news/abundnz-on-television/</link>
		<comments>http://www.abundnz.com/news/abundnz-on-television/#comments</comments>
		<pubDate>Tue, 13 Nov 2012 20:05:00 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=455</guid>
		<description><![CDATA[On Sunday 18 November 2012, special attention is paid to Abundnz in a television program from RTV Utrecht (Dutch regional television): BV Utrecht.]]></description>
			<content:encoded><![CDATA[<p>On Sunday 18 November 2012, special attention is paid to Abundnz in a television program from RTV Utrecht (Dutch regional television): <a title="Abundnz RTV Utrecht" href="http://vimeo.com/57739239" target="_blank">BV Utrecht</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/abundnz-on-television/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abundnz selected for oral presentation</title>
		<link>http://www.abundnz.com/news/abundnz-selected-for-oral-presentation/</link>
		<comments>http://www.abundnz.com/news/abundnz-selected-for-oral-presentation/#comments</comments>
		<pubDate>Mon, 13 Aug 2012 18:42:37 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=453</guid>
		<description><![CDATA[Abundnz is selected to give an oral presentation at the Services for Growth meeting on November 22, 2012.]]></description>
			<content:encoded><![CDATA[<p>Abundnz is selected to give an oral presentation at the <a title="Services for Growth" href="http://flandersbio.be/events/services-for-growth/" target="_blank">Services for Growth</a> meeting on November 22, 2012.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/abundnz-selected-for-oral-presentation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abundnz participant in Accenture Innovation Awards 2012</title>
		<link>http://www.abundnz.com/news/abundnz-participant-in-accenture-innovation-awards-2012/</link>
		<comments>http://www.abundnz.com/news/abundnz-participant-in-accenture-innovation-awards-2012/#comments</comments>
		<pubDate>Mon, 16 Jul 2012 19:11:57 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=449</guid>
		<description><![CDATA[Abundnz participates in a contest for the Accenture Innovation Awards 2012 in the category Health and Public Service.]]></description>
			<content:encoded><![CDATA[<p>Abundnz participates in a contest for the <a title="Accenture Innovation Awards" href="http://www.accenture.com/Microsites/innovation-awards/2012/nrg/Pages/index.aspx" target="_blank">Accenture Innovation Awards 2012</a> in the category Health and Public Service.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/abundnz-participant-in-accenture-innovation-awards-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abundnz in Top 100 of most innovative Dutch SME&#8217;s in 2012</title>
		<link>http://www.abundnz.com/news/abundnz-in-top-100-of-most-innovative-dutch-smes-in-2012/</link>
		<comments>http://www.abundnz.com/news/abundnz-in-top-100-of-most-innovative-dutch-smes-in-2012/#comments</comments>
		<pubDate>Tue, 05 Jun 2012 18:57:21 +0000</pubDate>
		<dc:creator>robert-jan</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://www.abundnz.com/?p=439</guid>
		<description><![CDATA[Today it was announced that Abundnz is in the Top 100 of most innovative Dutch SME&#8217;s in 2012.]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><img class="size-full wp-image-441 alignleft" title="mkb-2012-1" src="http://www.abundnz.com/wp-content/uploads/mkb-2012-1.png" alt="" width="83" height="131" />Today it was <a title="Innovation Top 100" href="http://www.syntens.nl/innovatietop100/top-100-2012/Nummer-99.aspx" target="_blank">announced</a> that Abundnz is in the Top 100 of most innovative Dutch SME&#8217;s in 2012.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.abundnz.com/news/abundnz-in-top-100-of-most-innovative-dutch-smes-in-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
